Journal article · 2026
Development and Preclinical Evaluation of 68Ga-Labeled BCMA-Targeting Nanobodies for PET Imaging of Multiple Myeloma
Journal of Medicinal Chemistry · Published 12 November 2026 · DOI 10.1021/acs.jmedchem.6c02377
In brief
“Development and Preclinical Evaluation of 68Ga-Labeled BCMA-Targeting Nanobodies for PET Imaging of Multiple Myeloma” is a 2026 journal article by Jingjing Yao and 8 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 0
- References
- 23
- Authors
- 9
Abstract
B-cell maturation antigen (BCMA) is a critical biomarker for multiple myeloma (MM). In this study, three 68Ga-labeled BCMA-targeting nanobodies (C02, C06, and C07) were developed and evaluated. Protein-based binding assays showed apparent nanomolar affinities, with dissociation constants of 58 ± 7 nM, 87 ± 9 nM, and 33 ± 3 nM, respectively. Their BCMA specificities… Read the full abstract at the publisher.
Excerpt. This paper is not open access.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Yao, J., Yan, J., Liu, T., Liu, Y., Zhang, R., Zhao, Z., Luo, Y., Li, J., & Zhang, X. (2026). Development and Preclinical Evaluation of 68Ga-Labeled BCMA-Targeting Nanobodies for PET Imaging of Multiple Myeloma. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02377
MLA 9
Yao, Jingjing, et al. “Development and Preclinical Evaluation of 68Ga-Labeled BCMA-Targeting Nanobodies for PET Imaging of Multiple Myeloma.” Journal of Medicinal Chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.6c02377.
Chicago
Yao, Jingjing, Jian Yan, Tianqing Liu, Yitong Liu, Rongrong Zhang, Zuoquan Zhao, Yaping Luo, Jian Li, and Xianzhong Zhang. 2026. “Development and Preclinical Evaluation of 68Ga-Labeled BCMA-Targeting Nanobodies for PET Imaging of Multiple Myeloma.” Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02377.
Harvard
Yao, J. et al. (2026) ‘Development and Preclinical Evaluation of 68Ga-Labeled BCMA-Targeting Nanobodies for PET Imaging of Multiple Myeloma’, Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.6c02377.
IEEE
J. Yao et al., “Development and Preclinical Evaluation of 68Ga-Labeled BCMA-Targeting Nanobodies for PET Imaging of Multiple Myeloma,” Journal of Medicinal Chemistry, 2026, doi: 10.1021/acs.jmedchem.6c02377.
BibTeX
@article{yao2026development,
title = {{Development and Preclinical Evaluation of 68Ga-Labeled BCMA-Targeting Nanobodies for PET Imaging of Multiple Myeloma}},
author = {Yao, Jingjing and Yan, Jian and Liu, Tianqing and Liu, Yitong and Zhang, Rongrong and Zhao, Zuoquan and Luo, Yaping and Li, Jian and Zhang, Xianzhong},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.6c02377},
url = {https://doi.org/10.1021/acs.jmedchem.6c02377}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- multiple myeloma
- BCMA
- nanobodies
- positron emission tomography
- NOTA chelator
- tumor targeting
- radioligand binding affinity
- tumor-to-muscle ratio
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Yao, J., Yan, J., Liu, T., Liu, Y., Zhang, R., Zhao, Z., Luo, Y., Li, J., & Zhang, X. (2026). Development and Preclinical Evaluation of 68Ga-Labeled BCMA-Targeting Nanobodies for PET Imaging of Multiple Myeloma. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02377
How many times has this paper been cited?
0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Jingjing Yao, Jian Yan, Tianqing Liu, Yitong Liu, Rongrong Zhang, Zuoquan Zhao, Yaping Luo, Jian Li, Xianzhong Zhang.
What is the DOI of this paper?
10.1021/acs.jmedchem.6c02377, permanently at https://doi.org/10.1021/acs.jmedchem.6c02377. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.